Pfizer has submitted an emergency authorization request for its coronavirus pill in the United States, a highly anticipated treatment because it can easily be taken at home in the first days after symptoms appear in the event of an infection.

The pharmaceutical giant has filed its request for this antiviral treatment with the United States Medicines Agency (FDA), he said in a statement.

Almost 90% efficiency

This antiviral treatment, which will be marketed under the name Paxlovid, has been shown to be 89% effective against hospitalizations and death in clinical trials, when taken within three days of symptom onset.

These trials were conducted by the company on people at high risk of developing a severe case of Covid-19.

They ingested the drug every 12 hours for five days.

“The overwhelming efficacy achieved in our clinical study of Paxlovid, and its ability to help save lives and keep people out of hospital if authorized, underscores the critical role that antiviral therapies can play in the battle. against Covid-19, ”said Pfizer boss Albert Bourla, quoted in the press release.

Another antiviral treatment

Antivirals work by decreasing the ability of a virus to replicate, thereby slowing down the disease.

These treatments represent a key complement to vaccines to protect against Covid-19.

The Washington Post reported on Tuesday that the U.S. government plans to announce the purchase of 10 million treatments this week.

Pfizer has said it plans to invest up to $ 1 billion to manufacture and distribute Paxlovid.

A voluntary license agreement was also announced Tuesday with the Medicines Patent Pool (MPP).

This agreement should allow generic manufacturers to produce the drug for supply to 95 countries with middle and lower income.

The American laboratory Merck has also developed an antiviral treatment, molnupiravir, authorized in early November in a first country, the United Kingdom.

An FDA committee is due to meet on November 30 to decide on the application for authorization of Merck's treatment in the United States.

Washington has already purchased 3.1 million treatments from Merck.

World

Coronavirus: Pfizer signed an agreement to facilitate global access to its pill against the virus

Economy

Coronavirus: Pfizer, BioNTech and Moderna rake in more than $ 1,000 in profits per second with their vaccines

  • epidemic

  • Covid 19

  • Coronavirus

  • World

  • United States

  • Pfizer-BioNTech

  • 0 comment

  • 0 share

    • Share on Messenger

    • Share on Facebook

    • Share on twitter

    • Share on Flipboard

    • Share on Pinterest

    • Share on Linkedin

    • Send by Mail

  • To safeguard

  • A fault ?

  • To print